Possible Mechanism and Current Recommendation of Thromboembolism in COVID-19 | Zendy

Dita Aulia Rachmi | Zendy; Eka Prasetya Budi Mulia | Zendy; Johanes Nugroho | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Possible Mechanism and Current Recommendation of Thromboembolism in COVID-19

Author(s) -

Dita Aulia Rachmi,

Eka Prasetya Budi Mulia,

Johanes Nugroho

Publication year - 2020

Publication title -

open access macedonian journal of medical sciences

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.288

H-Index - 17

ISSN - 1857-9655

DOI - 10.3889/oamjms.2020.4900

Subject(s) - medicine , covid-19 , intensive care medicine , pandemic , thrombosis , anticoagulant therapy , pulmonary embolism , disease , coronavirus , mortality rate , pathology , infectious disease (medical specialty) , outbreak

The coronavirus disease (COVID-19) has become a global pandemic with a high mortality rate. There has been emerging evidence regarding the presence of thrombosis in patients with severe COVID-19 infection. In addition, prognosis of COVID patients, once they are complicated with DVT or fatal pulmonary emboli, will also significantly decline. Hence, understanding the pathomechanism and prompt treatment of thromboembolism is important in improving the outcome in COVID-19 patients. Prophylaxis anticoagulant was proposed for all hospitalized COVID-19 patients. The aim of this article is to review the current literature regarding pathomechanism, risk assessment, diagnosis, and management of VTE.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research